Capecitabine in adjuvant radiochemotherapy for gastric adenocarcinoma

Data publikacji: 25 kwi 2014

Zakres stron: 189 - 196

Otrzymano: 28 cze 2013

Przyjęty: 13 sie 2013

DOI: https://doi.org/10.2478/raon-2013-0065

Słowa kluczowe

gastric cancer, capecitabine, adjuvant therapy, radiochemotherapy, survival, toxicity

© by Irena Oblak

This article is distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.